oxidopamine has been researched along with Benign Paroxysmal Positional Vertigo in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Benign Paroxysmal Positional Vertigo: Idiopathic recurrent VERTIGO associated with POSITIONAL NYSTAGMUS. It is associated with a vestibular loss without other neurological or auditory signs. Unlike in LABYRINTHITIS and VESTIBULAR NEURONITIS, inflammation in the ear is not observed.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, KL | 1 |
| Cheng, YY | 1 |
| Leu, HB | 1 |
| Lee, YY | 1 |
| Chen, TJ | 1 |
| Liu, DH | 1 |
| Kao, CL | 1 |
1 other study available for oxidopamine and Benign Paroxysmal Positional Vertigo
| Article | Year |
|---|---|
Investigating the role of Sirt1-modulated oxidative stress in relation to benign paroxysmal positional vertigo and Parkinson's disease.
Topics: Adrenergic Agents; Adult; Age Factors; Aged; Animals; bcl-2-Associated X Protein; Benign Paroxysmal | 2015 |